| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ding-Sheng Jiang | Q89763790 |
| P2093 | author name string | Xin Yi | |
| Xiang Wei | |||
| Xue-Hai Zhu | |||
| P2860 | cites work | Regulation of chromatin structure by site-specific histone H3 methyltransferases | Q24290115 |
| Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 | Q24336747 | ||
| G9a controls placental vascular maturation by activating the Notch Pathway | Q50440894 | ||
| NADPH oxidase 4 and endothelial nitric oxide synthase contribute to endothelial dysfunction mediated by histone methylations in metabolic memory | Q50544145 | ||
| Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats. | Q50924429 | ||
| The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling. | Q50956280 | ||
| The regulation of Jmjd3 upon the expression of NF-κB downstream inflammatory genes in LPS activated vascular endothelial cells. | Q51140949 | ||
| VEGF-A/Notch-Induced Podosomes Proteolyse Basement Membrane Collagen-IV during Retinal Sprouting Angiogenesis. | Q51429374 | ||
| Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications. | Q51542239 | ||
| Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. | Q51556854 | ||
| Pulmonary arterial hypertension: pathogenesis and clinical management. | Q52355584 | ||
| SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells. | Q52366367 | ||
| DNA Methylation and Histone Modification in Hypertension. | Q52591890 | ||
| UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease. | Q52725468 | ||
| Alternation of histone and DNA methylation in human atherosclerotic carotid plaques. | Q53498287 | ||
| Gestational diabetes mellitus impairs fetal endothelial cell functions through a mechanism involving microRNA-101 and histone methyltransferase enhancer of zester homolog-2. | Q54176556 | ||
| Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. | Q54284525 | ||
| EZH2 Inhibition Ameliorates Transverse Aortic Constriction-Induced Pulmonary Arterial Hypertension in Mice. | Q55040495 | ||
| 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the Eur | Q55058501 | ||
| Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques. | Q55069789 | ||
| The epigenetic landscape in the cardiovascular complications of diabetes | Q57022159 | ||
| Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension | Q58593702 | ||
| The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting | Q58789495 | ||
| The histone methyltransferase MLL is an upstream regulator of endothelial-cell sprout formation | Q58816250 | ||
| Adverse Epigenetic Signatures by Histone Methyltransferase Set7 Contribute to Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus | Q61865854 | ||
| HDAC6 is associated with the formation of aortic dissection in human | Q64104004 | ||
| Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy | Q68217674 | ||
| Optimizing treatment of hypertension in patients with diabetes | Q73924039 | ||
| Acute aortic dissection presenting with congestive heart failure: results from the International Registry of Acute Aortic Dissection | Q81055912 | ||
| Molecular mechanism of Jmjd3-mediated interleukin-6 gene regulation in endothelial cells underlying spinal cord injury | Q84112462 | ||
| Abnormal Epigenetic Modifications in Peripheral T Cells from Patients with Abdominal Aortic Aneurysm Are Correlated with Disease Development | Q89226572 | ||
| Epigenetic Mechanisms and Hypertension | Q90667057 | ||
| Class II transactivator (CIITA) mediates IFN-γ induced eNOS repression by enlisting SUV39H1 | Q91333735 | ||
| Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression | Q91595589 | ||
| Amelioration of Uremic Toxin Indoxyl Sulfate-Induced Osteoblastic Calcification by SET Domain Containing Lysine Methyltransferase 7/9 Protein | Q91726990 | ||
| Epigenetic Regulation of Vascular Diseases | Q91877987 | ||
| Epigenetic modification: a regulatory mechanism in essential hypertension | Q92341954 | ||
| Histone methyltransferase SMYD2: ubiquitous regulator of disease | Q92348528 | ||
| Giant cell arteritis | Q92417899 | ||
| Inhibition of polycomb repressor complex 2 ameliorates neointimal hyperplasia by suppressing trimethylation of H3K27 in vascular smooth muscle cells | Q92513319 | ||
| Protein methylation functions as the posttranslational modification switch to regulate autophagy | Q92921055 | ||
| Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics | Q93139190 | ||
| The SET-domain protein superfamily: protein lysine methyltransferases | Q24811144 | ||
| Epigenetic Modifications in Essential Hypertension | Q26749764 | ||
| Histone methyltransferases: novel targets for tumor and developmental defects | Q26775027 | ||
| Inflammation and metabolic dysfunction: links to cardiovascular diseases | Q26851186 | ||
| The placenta: a multifaceted, transient organ | Q27687553 | ||
| Histone methylation: a dynamic mark in health, disease and inheritance | Q28263573 | ||
| Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 | ||
| Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1 | Q28507470 | ||
| Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20 | Q28508566 | ||
| The histone demethylase, Jmjd1a, interacts with the myocardin factors to regulate SMC differentiation marker gene expression | Q28587066 | ||
| Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling | Q28587253 | ||
| Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice | Q28593600 | ||
| PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. | Q28594760 | ||
| The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer | Q28687241 | ||
| Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
| Role of smooth muscle cells in the initiation and early progression of atherosclerosis | Q30438867 | ||
| Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease | Q30454529 | ||
| HIF-KDM3A-MMP12 regulatory circuit ensures trophoblast plasticity and placental adaptations to hypoxia | Q31812581 | ||
| SWI/SNF chromatin remodeling enzymes are associated with cardiac hypertrophy in a genetic rat model of hypertension | Q33694215 | ||
| The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension | Q33702614 | ||
| Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2 | Q33813030 | ||
| Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. | Q34237731 | ||
| MRTF-A steers an epigenetic complex to activate endothelin-induced pro-inflammatory transcription in vascular smooth muscle cells | Q34249545 | ||
| Enhancer of zeste homolog 2 induces pulmonary artery smooth muscle cell proliferation | Q34291184 | ||
| Definitions and diagnosis of pulmonary hypertension. | Q34393150 | ||
| Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. | Q34485800 | ||
| Identification by high-throughput imaging of the histone methyltransferase EHMT2 as an epigenetic regulator of VEGFA alternative splicing | Q34712017 | ||
| Arterial-venous specification during development | Q34962630 | ||
| Ezh2-mediated repression of a transcriptional pathway upstream of Mmp9 maintains integrity of the developing vasculature. | Q34999341 | ||
| Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes | Q35405420 | ||
| Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension | Q35543481 | ||
| JMJD1A is a signal-sensing scaffold that regulates acute chromatin dynamics via SWI/SNF association for thermogenesis | Q35609053 | ||
| The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1α Stability and Angiogenesis | Q35749723 | ||
| Epigenetics of Atherosclerosis: Emerging Mechanisms and Methods | Q39177816 | ||
| Chromatin associated SETD3 negatively regulates VEGF expression | Q39187115 | ||
| Protein arginine methylation: a prominent modification and its demethylation | Q39212312 | ||
| Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells | Q39382895 | ||
| Global protein and histone arginine methylation are affected in a tissue-specific manner in a rat model of diet-induced hyperhomocysteinemia | Q39412770 | ||
| Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study | Q39433099 | ||
| The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. | Q40050639 | ||
| PRDM6 is enriched in vascular precursors during development and inhibits endothelial cell proliferation, survival, and differentiation | Q40100709 | ||
| LSD1 demethylates HIF1α to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis | Q40189675 | ||
| The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. | Q40427197 | ||
| Histone Methyltransferase SET1 Mediates Angiotensin II-Induced Endothelin-1 Transcription and Cardiac Hypertrophy in Mice | Q41151617 | ||
| Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis | Q41394362 | ||
| The Histone Methyltransferase Mixed Lineage Leukemia (MLL) 3 May Play a Potential Role on Clinical Dilated Cardiomyopathy | Q42262138 | ||
| S-adenosylhomocysteine induces inflammation through NFkB: A possible role for EZH2 in endothelial cell activation | Q43137066 | ||
| A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension | Q44938984 | ||
| Histone and DNA methylation-mediated epigenetic downregulation of endothelial Kruppel-like factor 2 by low-density lipoprotein cholesterol | Q46089387 | ||
| Pharmacological and transcriptional inhibition of the G9a histone methyltransferase suppresses proliferation and modulates redox homeostasis in human microvascular endothelial cells | Q46266480 | ||
| UKPDS and the legacy effect. | Q46325188 | ||
| Trophoblast lineage specification, differentiation and their regulation by oxygen tension | Q47273498 | ||
| TRIM48 Promotes ASK1 Activation and Cell Death through Ubiquitination-Dependent Degradation of the ASK1-Negative Regulator PRMT1. | Q47351709 | ||
| The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway | Q48099660 | ||
| Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome. | Q48372776 | ||
| Metformin regulates mitochondrial biogenesis and senescence through AMPK mediated H3K79 methylation: Relevance in age-associated vascular dysfunction | Q49794039 | ||
| Histone lysine methylation and congenital heart disease: From bench to bedside (Review). | Q50119941 | ||
| EZH2 inhibits autophagic cell death of aortic vascular smooth muscle cells to affect aortic dissection | Q50130159 | ||
| Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk | Q50233845 | ||
| Histone acetylation and methylation significantly change with severity of atherosclerosis in human carotid plaques | Q50235258 | ||
| Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals | Q35815589 | ||
| Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure | Q35829649 | ||
| Early mammalian erythropoiesis requires the Dot1L methyltransferase | Q35876889 | ||
| The Histone Demethylase PHF8 Is Essential for Endothelial Cell Migration | Q35890073 | ||
| Histone Methyltransferase Enhancer of Zeste Homolog 2-Mediated ABCA1 Promoter DNA Methylation Contributes to the Progression of Atherosclerosis | Q36050512 | ||
| Hyperhomocysteinemia in ApoE-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 via miR-92a Regulation | Q36218592 | ||
| Exposure to coplanar PCBs induces endothelial cell inflammation through epigenetic regulation of NF-κB subunit p65. | Q36326906 | ||
| Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes | Q36752495 | ||
| Developmental basis of vascular smooth muscle diversity | Q36767406 | ||
| BIX-01294 treatment blocks cell proliferation, migration and contractility in ovine foetal pulmonary arterial smooth muscle cells | Q36831427 | ||
| Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia | Q36916418 | ||
| The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer | Q36962818 | ||
| Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail | Q37163462 | ||
| Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice | Q37219745 | ||
| Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series). | Q37555457 | ||
| Meta-Analysis of Genome-Wide Association Studies for Abdominal Aortic Aneurysm Identifies Four New Disease-Specific Risk Loci | Q37597805 | ||
| Relevant issues in the pathology and pathobiology of pulmonary hypertension | Q37673917 | ||
| DOT1L promotes angiogenesis through cooperative regulation of VEGFR2 with ETS-1. | Q37688422 | ||
| KDM4B histone demethylase and G9a regulate expression of vascular adhesion proteins in cerebral microvessels | Q37714956 | ||
| Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis | Q38083011 | ||
| Structure and function of SET and MYND domain-containing proteins | Q38314974 | ||
| Critical roles of non-histone protein lysine methylation in human tumorigenesis | Q38329400 | ||
| Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). | Q38372331 | ||
| Epigenetics in the Vascular Endothelium: Looking From a Different Perspective in the Epigenomics Era. | Q38592594 | ||
| Histone methyltransferase Setd2 is critical for the proliferation and differentiation of myoblasts | Q38719055 | ||
| Inhibitors of Protein Methyltransferases and Demethylases. | Q38740496 | ||
| The novel EZH2 inhibitor, GSK126, suppresses cell migration and angiogenesis via down-regulating VEGF-A. | Q38792331 | ||
| Pulmonary arterial hypertension and associated conditions. | Q38809358 | ||
| Polycomb repressive complex 2 regulates MiR-200b in retinal endothelial cells: potential relevance in diabetic retinopathy | Q38885853 | ||
| Puerarin suppresses high glucose-induced MCP-1 expression via modulating histone methylation in cultured endothelial cells | Q38894056 | ||
| Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications | Q38903932 | ||
| A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy. | Q38906301 | ||
| PDE4 inhibition reduces neointima formation and inhibits VCAM-1 expression and histone methylation in an Epac-dependent manner | Q38914381 | ||
| Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy. | Q38935695 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 1 | |
| P304 | page(s) | 30 | |
| P577 | publication date | 2020-02-18 | |
| P1433 | published in | Clinical Epigenetics | Q18620113 |
| P1476 | title | Histone methylation and vascular biology | |
| P478 | volume | 12 |
Search more.